Microscopes in Massachusetts

JEOL Ltd. is a global manufacturer of scientific instruments, semiconductor equipment, industrial systems, and medical laboratory analyzers established in 1949. The company specializes in electron microscopy (transmission electron microscopes [TEM], scanning electron microscopes [SEM], field-emission SEMs), nuclear magnetic resonance (NMR) spectrometers, mass spectrometers (including AccuTOF-DART systems), and electron beam lithography systems for semiconductor manufacturing and research. JEOL also manufactures electron beam metal additive manufacturing (AM) systems, cross-section polishers (including the IB-19540CP and IB-19550CCP models), and clinical chemistry analyzers for laboratory applications. Primary markets include life science research (molecular biology, drug discovery, cryo-electron microscopy), semiconductor device characterization and manufacturing, materials science, industrial processing, and clinical diagnostics. The company serves universities, research institutions, semiconductor manufacturers, and medical laboratories worldwide. JEOL maintains regional operations across North America, Europe, Asia-Pacific, and the Middle East, with product lines tailored to semiconductor yield optimization, advanced materials characterization, structural biology research, and diagnostic chemistry. The company emphasizes high-resolution imaging, elemental analysis, spectroscopic capabilities, and integration of analytical workflows for research and production environments.

PathAI is an AI-driven digital pathology company providing cloud-native software solutions for anatomic pathology laboratories, biopharma organizations, and clinical research. The company specializes in AI-powered histopathology analysis and digital pathology workflow management. PathAI's flagship platform, AISight®, is a cloud-native, open-architecture enterprise solution that integrates case management, image management, and AI-based diagnostic tools to enable multiple histopathology use cases. The platform serves as a central hub for digital pathology workflows across academic medical centers, reference laboratories, and health systems. AISight® Dx received FDA clearance for primary diagnosis in June 2025. PathAI also offers specialized AI-assisted tools including AIM-MASH (FDA-qualified for metabolic-associated fatty liver disease clinical trials) and AIM-HI UC/IBDExplore for standardized histopathology endpoints in clinical trials. The company operates a proprietary pathologist contributor network of board-certified pathologists to support algorithm training and validation, with millions of annotations contributed. Services include BioPharma solutions for drug and diagnostic development, central laboratory operations, and anatomic pathology lab solutions. Notable partnerships include expanded collaboration with Labcorp to deploy FDA-cleared digital pathology nationwide. The company combines pathology domain expertise with machine learning to advance precision medicine, biomarker discovery, and clinical trial standardization.

Sakura Seiki Co., Ltd is a Japanese medical equipment manufacturer specializing in sterilization, disinfection, and pathology equipment for hospitals and healthcare facilities. The company operates multiple business divisions: infection control (sterilization and disinfection), pathology/cytology/immunology, and industrial/pharmaceutical sterilization solutions. Key product offerings include high-pressure steam sterilizers (MISORA® brand), instrument reprocessing systems, pathology equipment, and quality management systems for sterilized products (SSMS BASIC). The company maintains an Education Center providing training and seminars on sterilization management, infection control, and equipment operation. Sakura Seiki serves healthcare providers, central sterile processing departments, and pharmaceutical manufacturers across Japan and internationally. The company is actively engaged in professional conferences and exhibitions, including participation in infection management and sterilization-focused academic meetings. Manufacturing capabilities span industrial, pharmaceutical, food, and medical-grade equipment. The company holds relevant medical device approvals and certifications for Japanese and international markets.

BEGO (Bremer Goldschlägererei Wilh. Herbst GmbH & Co.) is a Germany-based dental technology and implant solutions manufacturer offering comprehensive product lines spanning 3D printing, CAD/CAM solutions, dental implants, and conventional dental technology. The company specializes in digital dentistry workflows and supplies materials, equipment, software, and professional services to dental technicians and dental practices. 3D Printing Solutions: BEGO manufactures proprietary 3D printing resins including VarseoSmile TriniQ (a tooth-colored material for dentures and temporary restorations), VarseoSmile Crown plus (ceramic-filled hybrid for permanent crowns, inlays, onlays, veneers), VarseoSmile Temp, and VarseoWax materials for model and investment casting applications. The company provides compatibility guidance for major 3D printer systems. CAD/CAM Solutions: BEGO operates production facilities offering Selective Laser Melting (SLM), High Speed Cutting (HSC), CAD/Cast, and digital model production services. Core CAD/CAM materials include zirconium dioxide (BEGO Zirkon ST, Zirkon LT, KATANA, VITA systems), acrylics (PMMA multicolor, splint materials), non-precious and precious metal alloys (WIRONIUM RP series, Mediloy, Wirobond, Bio PontoStar, PontoLloyd), and glass ceramics (IPS e.max CAD). Applications include partial dentures, crowns, bridges, telescopic double crowns, implant prosthetics, digital dentures, orthodontic appliances, and splints. Dental Implant Systems: BEGO Semados implant platform includes RSX Pro Conical Connection, SCX Conical Connection, and RS/RSX/SC/SCX implant variants. The company offers implant prosthetics (abutments, healing posts, bridges, bar structures), guided surgical solutions (BEGO Guide surgical guides and planning systems), and regenerative materials (naturesQue bone grafts and membranes: SemOss B, MaxOss P, ColTect P, ColAid P). Digital Infrastructure: BEGO provides intraoral scanner integrations (Medit, 3Shape), CAD/CAM software (3Shape, exocad, proprietary BEGO software), order portals (BEGO CAD/CAM Orderportal, BEGO Guide portal), and customer support via TeamViewer and remote consultation. The company maintains a Scan and Design Centre and offers technical bulletins, declarations of conformity, and material libraries. Conventional Dental Technology: Work preparation, duplicating, modeling, embedding, casting alloys, laser cutting, and surface treatment supplies via BEGO eShop. The company holds relevant dental device certifications and maintains ISO compliance. BEGO operates production centers in Bremen, Germany, with international distribution networks and professional education/training programs for dental professionals.

Harvard Bioscience Inc is a holding company and distributor of laboratory and research equipment serving academic institutions, contract research organizations (CROs), pharmaceutical, and biotech companies. The company operates through multiple subsidiary brands including Data Sciences International (DSI), BTX Electroporation Systems, Multi Channel Systems (MCS), Biochrom, HEKA, Harvard Apparatus, Panlab, Warner Instruments, CMA Microdialysis, and Hugo Sachs Elektronik. Product portfolio encompasses electrophysiology systems (patch clamp amplifiers, multielectrode arrays, Ussing chambers), spectrophotometers and colorimeters (Ultrospec series, Biowave), amino acid analyzers, telemetry and behavioral monitoring systems, electroporation devices, and isolated organ perfusion systems. The company serves discovery, production, and regulatory compliance workflows for life-saving therapeutic development. Products include the INCUB8 multiwell MEA system for optical and electrophysiological recording, HEKA EPC 10 USB 3.0 patch clamp amplifier, IntraCell laser-based optoporation system, VivaMARS activity monitoring platform, Ponemah software (GLP and 21 CFR Part 11 compliant), continuous glucose telemetry for rodents, and various UV-Vis spectrophotometric instruments. The company actively participates in major scientific conferences including SfN, APS, ECS, and ISSCR, and maintains active engagement in neuroscience, cardiac, and translational research communities.

Miltenyi Biotec is a biotech company specializing in cell isolation, separation, and analysis technologies for research and clinical applications. The company manufactures MACS® (Magnetic Cell Separation) systems and reagents for isolating and purifying specific cell populations from complex samples. Key product lines include MicroBead Kits (e.g., StraightFrom Spleen kits for rapid immune cell isolation from mouse tissue in 15 minutes), flow cytometry instruments and software (MACSQuantify with express modes for standardized, automated workflows), and imaging analysis software (MACS iQ View 3D for large-volume image datasets). The company also offers the MACS Catalyst Program, providing guidance, instrument placement, and regulatory support (IND pathways) for cell and gene therapy developers in North America. Products target research institutions, clinical laboratories, and cell therapy manufacturers. The company supports procurement via purchase orders and maintains an online product catalog. While the fetched content does not explicitly detail FDA clearances or ISO certifications, Miltenyi Biotec is known for manufacturing life science research tools and clinical-grade cell separation systems used in regulated environments. Headquarters appear to be in Germany (Bergisch Gladbach, Rhineland) with North American operations.

HAI Laboratories, Inc. is an ISO 13485-certified U.S. manufacturer of ophthalmic diagnostic equipment and imaging systems headquartered in Lexington, MA since 1996. The company specializes in clinical, eye bank, and laboratory specular microscopes—the only American manufacturer of these instruments in operation today. HAI produces digital video slit lamps with advanced 3CCD technology for anterior segment imaging, high-resolution endothelial imaging systems for corneal analysis, and custom-configured specular microscopy platforms. The company also develops proprietary image processing and analysis software systems for ophthalmic applications. In addition to diagnostic equipment, HAI manufactures precision ophthalmic microsurgical instruments and motorized microscope stands. Known for user-driven product development and modular system design, HAI offers factory-direct pricing, equipment rentals, professional installation, on-site training, and validation services to eye banks, hospitals, universities, and private clinics worldwide.

Firefly Global is a leading manufacturer of wireless portable digital magnifying cameras and video transmission systems for medical and veterinary professionals. The company specializes in high-definition digital imaging devices including wireless video otoscopes for ENT and audiology, endoscope camera systems with universal couplers for EMR integration, digital dermatoscopes with advanced polarizing optics, and telemedicine peripherals compatible with iPhone, iPad, Android, Windows, and Mac OS. Firefly's product portfolio also includes scientific and industrial digital microscopes with magnification up to 230x, veterinary examination tools, and precision accessories such as specula dispensers and TV adapters. Serving hospitals, clinics, medical schools, and veterinary practices across North America, Europe, and Asia, Firefly devices enable clinicians and specialists to capture, document, and stream high-quality live video for improved patient evaluation, education, and remote healthcare delivery.

Hamilton Thorne is a leading manufacturer of precision laser systems, CASA (Computer Assisted Sperm Analysis) systems, imaging systems, consumables, and services for assisted reproductive technology (ART) and developmental biology research. For over 30 years, the company has served IVF clinics, fertility centers, animal breeding operations, pharmaceutical companies, and research laboratories worldwide. Core products include sperm analyzers that measure motility and morphology; AI-enabled laser systems for embryo manipulation and selection; the Oosight Imaging System for oocyte assessment; micropipettes for micromanipulation; embryo culture media; and ancillary lab equipment including air purification systems, incubators, and IVF workstations. Hamilton Thorne's solutions support human fertility treatment, animal reproduction (equine, poultry, livestock), and research applications in toxicology, drug safety, and stem cell development. Manufacturing is ISO-certified and conducted in-house in the USA.

MetaSystems International GmbH is a global developer and manufacturer of automated microscopy system software and hardware, headquartered in Germany with operations established since 1986. The company serves clinical laboratories and research institutions across 103 countries with solutions for automated image capture, analysis, and workflow management in cytology and pathology applications. Primary product lines include the Metafer automated microscopy platform with AI-enabled imaging modules (sperm detection, forensic casework support) and the Ikaros image analysis system. MetaSystems also maintains a separate Probes division (MetaSystems Probes GmbH) specializing in XCyting DNA fluorescence probes for FISH and molecular diagnostics. The company is recognized for developing deep neural network-based imaging solutions, recently granted an EU patent for AI imaging technology. Products are marketed to forensic pathology, clinical cytology, and hematology laboratories. MetaSystems operates subsidiary offices and authorized distribution partners across major regions including USA, Latin America, Italy, India, China, Hong Kong, and Japan, with direct support teams in Germany.

Nexpring Health is a global MedTech company focused on Assisted Reproductive Technology (ART), formed in 2025 through the combination of Hamilton Thorne, Cook Medical's Reproductive Health business, FUJIFILM Irvine Scientific's Medical Media Business, and several other specialized fertility providers. Headquartered in Beverly, Massachusetts, the company brings together over 40 years of cumulative industry expertise to serve embryologists, clinicians, and fertility clinics worldwide. Nexpring Health offers a comprehensive end-to-end ART portfolio encompassing innovative devices, culture media, consumables, and support services designed for every stage of the IVF cycle—from pre-IVF diagnosis and sperm preparation through ovum pickup, fertilization, embryo development, embryo transfer, and cryopreservation. Key products include the Guardia™ Access Embryo Transfer Catheter family, Gynemed Specialty Media formulations, CASA systems for semen analysis, embryo culture media, cryopreservation equipment (Kryo series), incubators, aspiration needles, micromanipulation instruments, and laboratory monitoring systems. The company emphasizes streamlined workflows, product quality, and direct collaboration with ART professionals to address challenges in fertility clinic operations and improve patient outcomes.

BioView is a leading developer and manufacturer of automated cell imaging and analysis solutions for cytogenetics, oncology, and pathology laboratories. With nearly two decades of expertise, BioView specializes in diagnostic automation technology, particularly automated FISH (Fluorescence In Situ Hybridization) imaging and analysis. The company's comprehensive product portfolio includes the Cytogenetics Suite featuring automated karyotyping and FISH imaging platforms, as well as scanning systems ranging from manual workstations to fully automated loaders. BioView offers FDA-cleared and CE-marked applications for diverse diagnostics including hematology, prenatal testing, circulating tumor cell detection, and oncology applications. The company provides web-based analysis tools enabling case analysis and reporting from any location without software installation. BioView's systems are designed to enhance laboratory efficiency, accuracy, and standardization across diverse clinical and research workflows.

Lunit International Limited is a healthcare AI software company specializing in cancer detection and precision oncology. Founded in 2013 with headquarters in Seoul and offices in Boston, the company develops clinically validated, FDA-cleared AI solutions that enhance cancer screening and treatment optimization. Lunit's modular ecosystem integrates imaging analysis, digital pathology, and biomarker intelligence across radiology, pathology, and oncology workflows. The platform serves over 10,000 customer sites across 65+ countries, with deployments focused on early detection in breast cancer, lung cancer, and personalized treatment selection through AI-powered biomarker analysis and immunohistochemistry quantification.

Intelon Optics is a medical device company specializing in advanced Brillouin Optical Scanning System (BOSS®) technology for real-time, high-resolution 3D biomechanical imaging. The FDA-cleared and CE-marked BOSS® for Ophthalmology provides non-contact measurement of ocular-tissue elasticity and stiffness, enabling evaluation of corneal biomechanics, keratoconus assessment, and glaucoma/corneal pathology analysis. The company also offers BOSS® LS for label-free, sub-micron 3D cellular and tissue research, and BOSS® IVF, a research platform analyzing viscoelastic properties of oocytes, embryos, and sperm for reproductive science applications. With extensive clinical validation and adoption by leading eye clinics and universities globally, Intelon Optics addresses unmet diagnostic needs in refractive surgery planning, keratoectasia prediction, and biomechanical tissue characterization across ophthalmology and life sciences research.

CellTivity Scientific is a medical technology company specializing in live-cell imaging platforms for real-time assessment of cellular behavior, morphology, and metabolic activity. The flagship Van Gogh Microscopy System utilizes proprietary Dynamic Cell Imaging (DCI) technology to provide non-invasive visualization of metabolic activity and tissue adequacy during biopsies. The system enables proceduralists to identify cell types—including cancer cells, immune cells, and granuloma—and assess biopsy sample quality in real time, improving diagnostic yield and reducing biopsy inadequacy. Applications span interventional pulmonology, thoracic procedures, bronchoscopy, and general tissue sampling across oncology specialties. The company offers CE-registered devices with deployment, training, and pathology integration support to hospitals and clinics, targeting enhanced point-of-care diagnostics and streamlined collaboration with pathology departments.